2026 Annual Conference Chairs

Rachel Guest, PhD

Rachel Guest is a Consultant HPB Surgeon and Clinician Scientist at the Institute of Cancer and Genetics, University of Edinburgh UK.  She completed her higher surgical training and advanced surgical fellowship in HPB and Transplant Surgery at the Royal Infirmary of Edinburgh.  She undertook her PhD with Professor Stuart Forbes at the Centre for Regenerative Medicine, where her work focussed on the role of Notch signalling in cholangiocarcinoma.  Her lab now studies how IDH1/2 mutations drive intrahepatic cholangiocarcinoma, using pre-clinical models and multi-omic approaches to understand how D-2HG shapes liver cell identity and the epigenome.  Her research is supported by Wellcome, AMMF and CCF. 

Gregory B. Lesinski, PhD, MPH

Gregory B. Lesinski, PhD, MPH, is professor and serves as vice chair for basic research in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Lesinski also serves as Winship Cancer Institute's associate director for basic research and shared resources where he provides oversight and direction for the development and growth of Winship's basic scientific activities across the cancer center’s four research programs. He also is the Scientific Co-Director for the Winship Cellular Therapy Initiative and co-leads the Translational GI Malignancy Program. Prior to joining Emory, Dr. Lesinski was associate professor in the Department of Internal Medicine, Division of Medical Oncology at The Ohio State University.